CD44 and breast carcinoma: Our previous work showed that breast cancer stem cells express CD44+CD24− (Al-Hajj et al., 2003) or ALDH+ (Ginestier et al., 2007), and that these two markers isolate distinct populations of mesenchymal-like and epithelial-like cells, respectively (Liu et al., 2013).